Clinical and regulatory development by current and future products.

The FDA clearance of the Hologic Advanced Body Composition Assessment package opens up a new market for the Hologic Discovery whole body DXA systems that have been used so far primarily for osteoporosis to be measured in women after they reach menopause.

Body mass measurement on our Discovery systems is another important milestone for Hologic and our skeletal health business, said John Jenkins, Vice President and General Manager of the Hologic Skeletal Health business. Our new Advanced Body Composition assessment package provides a more accurate and consistent baseline for measuring body mass changes than bio-impedance testing and hydrostatic weighing and skin fold thickness. This new indication is a major step forward in helping maintain the quality of life of men and women, and we hope that to be the standard of care for children and adults. .Discover or identification of new product candidates are is not guaranteed and motion from concepts up to product is insecure may be can no guarantee to any particular product candidate will be successful and to commercial product is. Further, some raw materials, follow-up components for our products supplied with the sole third-party.. No forward-looking guaranteed guaranteed and the actual results may differ materially from ones we the project. Results the company may by our ability successfully market New and returning products domestically and International Websites, clinical and regulatory development by current and future products, as well as U.S.

Other entries from category "urology":

Random entries